Deep historical borrowing framework to prospectively and simultaneously synthesize control information in confirmatory clinical trials with multiple endpoints

被引:2
|
作者
Zhan, Tianyu [1 ]
Zhou, Yiwang [2 ]
Geng, Ziqian [1 ]
Gu, Yihua [1 ]
Kang, Jian [3 ]
Wang, Li [1 ]
Huang, Xiaohong [1 ]
Slate, Elizabeth H. [4 ]
机构
[1] AbbVie Inc, Data & Stat Sci, 1 Waukegan Rd, N Chicago, IL 60064 USA
[2] St Jude Childrens Res Hosp, Dept Biostat, 332 N Lauderdale St, Memphis, TN 38105 USA
[3] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA
[4] Florida State Univ, Dept Stat, Tallahassee, FL 32306 USA
关键词
Bayesian hierarchical model; deep learning; family-wise error rate control; power preservation; prospective algorithm; SECUKINUMAB; PSORIASIS;
D O I
10.1080/10543406.2021.1975128
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In current clinical trial development, historical information is receiving more attention as it provides utility beyond sample size calculation. Meta-analytic-predictive (MAP) priors and robust MAP priors have been proposed for prospectively borrowing historical data on a single endpoint. To simultaneously synthesize control information from multiple endpoints in confirmatory clinical trials, we propose to approximate posterior probabilities from a Bayesian hierarchical model and estimate critical values by deep learning to construct pre-specified strategies for hypothesis testing. This feature is important to ensure study integrity by establishing prospective decision functions before the trial conduct. Simulations are performed to show that our method properly controls family-wise error rate and preserves power as compared with a typical practice of choosing constant critical values given a subset of null space. Satisfactory performance under prior-data conflict is also demonstrated. We further illustrate our method using a case study in Immunology.
引用
收藏
页码:90 / 106
页数:17
相关论文
共 20 条